SNT Change in substantial holding 05/07/23 download Created with Sketch. 585.34KB Share SNT Investor presentation 24/05/23 download Created with Sketch. 1.37MB Share SNT PXS Announces Encouraging Results from Phase 1c Scar Study 23/05/23 PRICE SENSITIVE download Created with Sketch. 235.37KB Share SNT Trading Halt 22/05/23 PRICE SENSITIVE download Created with Sketch. 369.47KB Share SNT Investor Presentation - Quarterly Briefing 28/04/23 download Created with Sketch. 1.02MB Share SNT Quarterly Activities/Appendix 4C Cash Flow Report 28/04/23 PRICE SENSITIVE download Created with Sketch. 625.51KB Share SNT Quarterly Activities/Appendix 4C Cash Flow Report 28/04/23 PRICE SENSITIVE download Created with Sketch. 323.77KB Share SNT PXS Quarterly Update and Investor Briefing 21/04/23 download Created with Sketch. 203.05KB Share SNT After FDA Review PXS Accelerates Plans for Combination Study 12/04/23 PRICE SENSITIVE download Created with Sketch. 223.25KB Share SNT Ceasing to be a substantial holder 31/03/23 download Created with Sketch. 96.21KB Share SNT Pharmaxis Drug Study Published in Nature Communications 23/03/23 download Created with Sketch. 215.64KB Share SNT Becoming a substantial holder 22/03/23 download Created with Sketch. 114.34KB Share SNT Change in substantial holding 21/03/23 download Created with Sketch. 88.92KB Share SNT Application for quotation of securities - PXS 20/03/23 download Created with Sketch. 24.95KB Share SNT Application for quotation of securities - PXS 16/03/23 download Created with Sketch. 25.35KB Share SNT Change in substantial holding 13/02/23 download Created with Sketch. 623.85KB Share SNT PXS Securities Trading Policy - Updated 10 Feb 2023 13/02/23 download Created with Sketch. 226.79KB Share SNT Half Yearly Report and Accounts 10/02/23 PRICE SENSITIVE download Created with Sketch. 718.73KB Share SNT Investor Presentation 06/02/23 download Created with Sketch. 2.7MB Share SNT Investor Presentation 31/01/23 download Created with Sketch. 571.67KB Share SNT Quarterly Activities Report 31/01/23 PRICE SENSITIVE download Created with Sketch. 529.73KB Share SNT Quarterly Activities/Appendix 4C Cash Flow Report 31/01/23 PRICE SENSITIVE download Created with Sketch. 219.35KB Share SNT Quarterly Shareholder Update and Investor Briefing 23/01/23 download Created with Sketch. 128.55KB Share SNT Application for quotation of securities - PXS 23/01/23 download Created with Sketch. 24.94KB Share SNT Initial Director's Interest Notice 16/01/23 download Created with Sketch. 136.62KB Share SNT Director Appointment/Resignation 16/01/23 download Created with Sketch. 107.75KB Share SNT Pharmaxis Receives $5m R&D Tax Incentive 09/01/23 download Created with Sketch. 86.6KB Share SNT Application for quotation of securities - PXS 22/12/22 download Created with Sketch. 24.94KB Share SNT Pharmaxis Skin Scarring Study Fully Recruited 21/12/22 download Created with Sketch. 171.86KB Share SNT Initial Director's Interest Notice 14/12/22 download Created with Sketch. 134.47KB Share SNT Pharmaxis Appoints Dr Simon Green as Director 14/12/22 download Created with Sketch. 108.42KB Share SNT Change in substantial holding 14/12/22 download Created with Sketch. 202.71KB Share SNT PXS Drug Profiled American Society of Hematology Conference 12/12/22 download Created with Sketch. 203.31KB Share SNT Application for quotation of securities - PXS 12/12/22 download Created with Sketch. 24.94KB Share SNT Change in substantial holding 08/12/22 download Created with Sketch. 161.16KB Share SNT Becoming a substantial holder 07/12/22 download Created with Sketch. 618.16KB Share SNT Change in substantial holding 06/12/22 download Created with Sketch. 173.11KB Share SNT Section 708(5)(e) Notice 05/12/22 download Created with Sketch. 140.88KB Share SNT Ceasing to be a substantial holder 02/12/22 download Created with Sketch. 615.92KB Share SNT Change of Director's Interest Notice 02/12/22 download Created with Sketch. 140.49KB Share SNT Change of Director's Interest Notice 02/12/22 download Created with Sketch. 143.55KB Share SNT Change of Director's Interest Notice 02/12/22 download Created with Sketch. 145.38KB Share SNT Notification regarding unquoted securities - PXS 02/12/22 download Created with Sketch. 28.3KB Share SNT Application for quotation of securities - PXS 02/12/22 download Created with Sketch. 23.16KB Share SNT Change of Director's Interest Notice 29/11/22 download Created with Sketch. 139.34KB Share SNT Notification regarding unquoted securities - PXS 29/11/22 download Created with Sketch. 25.39KB Share SNT Results of Meeting 29/11/22 download Created with Sketch. 212.72KB Share SNT Chairman's Address to Shareholders 29/11/22 download Created with Sketch. 175.76KB Share SNT CEO Presentation to 2022 AGM 29/11/22 download Created with Sketch. 2.1MB Share SNT Application for quotation of securities - PXS 23/11/22 download Created with Sketch. 24.91KB Share SNT Investor Presentation 09/11/22 download Created with Sketch. 1.78MB Share SNT Application for quotation of securities - PXS 07/11/22 download Created with Sketch. 25.31KB Share SNT Change of Director's Interest Notice 01/11/22 download Created with Sketch. 145.21KB Share SNT Application for quotation of securities - PXS 01/11/22 download Created with Sketch. 27.02KB Share SNT Change of Director's Interest Notice 01/11/22 download Created with Sketch. 142.2KB Share SNT Application for quotation of securities - PXS 01/11/22 download Created with Sketch. 25.47KB Share SNT Quarterly Activities Report 31/10/22 PRICE SENSITIVE download Created with Sketch. 869.62KB Share SNT Quarterly Activities/Appendix 4C Cash Flow Report 31/10/22 PRICE SENSITIVE download Created with Sketch. 219.1KB Share SNT Becoming a substantial holder 28/10/22 download Created with Sketch. 87.05KB Share SNT Corporate Governance Statement 28/10/22 download Created with Sketch. 189.65KB Share SNT Appendix 4G 28/10/22 download Created with Sketch. 186.18KB Share SNT Annual Report to shareholders 28/10/22 download Created with Sketch. 1.24MB Share SNT Notice of Annual General Meeting/Proxy Form 28/10/22 download Created with Sketch. 420.6KB Share SNT Change in substantial holding 28/10/22 download Created with Sketch. 185.65KB Share SNT Becoming a substantial holder 27/10/22 download Created with Sketch. 253.44KB Share SNT Section 708A(5)(e) Notice 26/10/22 download Created with Sketch. 140.87KB Share SNT Application for quotation of securities - PXS 26/10/22 download Created with Sketch. 24.57KB Share SNT Proposed issue of securities - PXS 19/10/22 download Created with Sketch. 25.38KB Share SNT Proposed issue of securities - PXS 19/10/22 download Created with Sketch. 25.12KB Share SNT PXS announces positive interim data from myelofibrosis trial 19/10/22 PRICE SENSITIVE download Created with Sketch. 257.53KB Share SNT Investor Presentation 19/10/22 PRICE SENSITIVE download Created with Sketch. 1.56MB Share SNT Placement 19/10/22 PRICE SENSITIVE download Created with Sketch. 223.88KB Share SNT Trading Halt 18/10/22 PRICE SENSITIVE download Created with Sketch. 372.8KB Share SNT Proposed Issue of Securities to Chief Executive Officer 18/10/22 download Created with Sketch. 159.29KB Share SNT Notification regarding unquoted securities - PXS 18/10/22 download Created with Sketch. 26.59KB Share SNT Investor Presentation Interim Data from Skin Scarring Study 26/09/22 download Created with Sketch. 1MB Share SNT PXS Releases Promising Interim Data from Skin Scarring Study 26/09/22 PRICE SENSITIVE download Created with Sketch. 182.78KB Share SNT Date of Virtual AGM and Date for Director Nominations 13/09/22 download Created with Sketch. 178.58KB Share SNT Investor presentation 06/09/22 download Created with Sketch. 1.05MB Share SNT Application for quotation of securities - PXS 01/09/22 download Created with Sketch. 24.91KB Share SNT PXS to Receive Stg2.9m from Parkinsons UK for New Trial 01/09/22 PRICE SENSITIVE download Created with Sketch. 208.6KB Share SNT Preliminary Final Report 30/08/22 PRICE SENSITIVE download Created with Sketch. 859.7KB Share SNT Change of Director's Interest Notice 23/08/22 download Created with Sketch. 144.17KB Share SNT Notification of cessation of securities - PXS 23/08/22 download Created with Sketch. 21.68KB Share SNT Notification of cessation of securities - PXS 22/08/22 download Created with Sketch. 21.51KB Share SNT Pharmaxis Receives Aptar Option Exercise Fees of US$5m 16/08/22 download Created with Sketch. 108.87KB Share SNT Final Director's Interest Notice 05/08/22 download Created with Sketch. 113.2KB Share SNT Director Appointment/Resignation 05/08/22 download Created with Sketch. 114.52KB Share SNT Aptar Pharma Pays PXS Us$5m to Acquire Orbital Technology 04/08/22 PRICE SENSITIVE download Created with Sketch. 167.45KB Share SNT Investor presentation for quarterly shareholder update 29/07/22 download Created with Sketch. 916.85KB Share SNT Investor presentation 29/07/22 download Created with Sketch. 1.86MB Share SNT Quarterly Activities/Appendix 4C Cash Flow Report 29/07/22 PRICE SENSITIVE download Created with Sketch. 471.83KB Share SNT Quarterly Appendix 4C Cash Flow Report 29/07/22 PRICE SENSITIVE download Created with Sketch. 199.5KB Share SNT Pharmaxis Quarterly Shareholder Update and Investor Briefing 26/07/22 download Created with Sketch. 122.24KB Share SNT Results of Meeting 11/07/22 download Created with Sketch. 177.38KB Share SNT Notification regarding unquoted securities - PXS 01/07/22 download Created with Sketch. 25.28KB Share SNT Appointment of Dr Jana Baskar as Chief Medical Officer 01/07/22 download Created with Sketch. 108.88KB Share SNT Application for quotation of securities - PXS 15/06/22 download Created with Sketch. 24.94KB Share SNT Notice of General Meeting/Proxy Form 08/06/22 download Created with Sketch. 322.61KB Share SNT Application for quotation of securities - PXS 30/05/22 download Created with Sketch. 24.92KB Share